CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-20 | BARNES SUSAN K EVP, CFO and PAO | Option exercise · Stock Option (right to buy) | −250,000 | 0 | ||
| 2018-12-20 | BARNES SUSAN K EVP, CFO and PAO | Option exercise · Stock Option (right to buy) | −48,762 | 0 | ||
| 2018-12-20 | BARNES SUSAN K EVP, CFO and PAO | Option exercise · Stock Option (right to buy) | −18,228 | 69,272 | ||
| 2018-11-27 | ORDONEZ KATHY Chief Commercial Officer | Option exercise | +25,000 | $2.90 | $73K | 68,750 |
| 2018-11-27 | ORDONEZ KATHY Chief Commercial Officer | Sale | −25,000 | $7.54 | $189K | 43,750 |
| 2018-11-27 | ORDONEZ KATHY Chief Commercial Officer | Grant or award · Stock Option (right to buy) | −25,000 | 350,000 | ||
| 2018-07-27 | HENRY CHRISTIAN O Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2018-05-22 | Shapiro Lucy Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-05-22 | MOHR MARSHALL Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-05-22 | MILLIGAN JOHN F Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-05-22 | LIVINGSTON RANDALL S Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-05-22 | Ericson William W. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-05-22 | Botstein David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-03-15 | ORDONEZ KATHY Chief Commercial Officer | Grant or award | +43,750 | 43,750 | ||
| 2018-03-15 | ORDONEZ KATHY Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +87,500 | 87,500 | ||
| 2018-03-15 | BARNES SUSAN K EVP, CFO and PAO | Grant or award | +43,750 | 391,167 | ||
| 2018-03-15 | BARNES SUSAN K EVP, CFO and PAO | Grant or award · Stock Option (right to buy) | +87,500 | 87,500 | ||
| 2018-03-15 | Hunkapiller Michael Chairman, CEO & President | Grant or award | +50,000 | 2,350,000 | ||
| 2018-03-15 | Hunkapiller Michael Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-02-15 | Phillips James Michael SVP, Research & Development | Grant or award | +15,000 | 209,166 |
Page 22 of 29 · 561 trades